MAI Capital Management - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$1,526,518
-27.5%
455,677
-6.1%
0.02%
-25.8%
Q2 2023$2,105,108
+13.5%
485,048
-1.9%
0.03%
+6.9%
Q1 2023$1,855,088
+19.4%
494,690
+12.4%
0.03%
+11.5%
Q4 2022$1,553,451
+116.7%
440,071
+23.3%
0.03%
+100.0%
Q3 2022$717,000356,9480.01%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Regency Capital Management Inc.\DE 15,000$79,0000.06%
Ikarian Capital, LLC 119,551$632,0000.05%
NORRIS PERNE & FRENCH LLP/MI 78,909$417,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 23,445$124,0000.02%
Stokes Family Office, LLC 12,120$64,0000.01%
MARSHALL WACE, LLP 329,131$1,738,0000.01%
Cornerstone Capital, Inc. 11,357$60,0000.01%
MCF Advisors LLC 9,499$50,0000.01%
Cutler Group LLC / CA 7,900$41,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 13,389$71,0000.00%
View complete list of OCUPHIRE PHARMA INC shareholders